EFNA1
Ephrin-A1
Also known as: ECKLG, EFNA1_HUMAN, EPLG1, GMAN, LERK1, TNFAIP4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20827
- Gene
- EFNA1
- Ensembl
- ENSG00000169242
- Chromosome
- 1
- Canonical length
- 205 aa
- Protein class
- Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin which binds to the EPHA2, EPHA4, EPHA5, EPHA6, and EPHA7 receptors. Two transcript variants that encode different isoforms were identified through sequence analysis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
205 residues, UniProt reviewed canonical sequence.
>P20827|EFNA1
1 MEFLWAPLLG LCCSLAAADR HTVFWNSSNP KFRNEDYTIH VQLNDYVDII CPHYEDHSVA
61 DAAMEQYILY LVEHEEYQLC QPQSKDQVRW QCNRPSAKHG PEKLSEKFQR FTPFTLGKEF
121 KEGHSYYYIS KPIHQHEDRC LRLKVTVSGK ITHSPQAHDN PQEKRLAADD PEVRVLHSIG
181 HSAAPRLFPL AWTVLLLPLL LLQTPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EFNA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 477 nTPM
Expression across tissuesHPA
Tissue
- liver: 477 nTPM
- skin: 132 nTPM
- placenta: 103 nTPM
- lung: 92 nTPM
- thyroid gland: 86 nTPM
- prostate: 85 nTPM
Single-cell type
- extravillous trophoblasts: 1,373 nCPM
- migrating cytotrophoblasts: 583 nCPM
- syncytiotrophoblasts: 299 nCPM
- alveolar cells type 1: 299 nCPM
- prostatic club cells: 256 nCPM
- breast secretory cells: 252 nCPM
Immune cell
- naive CD4 T-cell: 12 nTPM
- naive CD8 T-cell: 5.9 nTPM
- total PBMC: 1.6 nTPM
- memory CD4 T-cell: 1 nTPM
- gdT-cell: 0.8 nTPM
- memory CD8 T-cell: 0.7 nTPM
Brain region
- white matter: 32 nTPM
- medulla oblongata: 25 nTPM
- basal ganglia: 21 nTPM
- midbrain: 20 nTPM
- cerebral cortex: 20 nTPM
- pons: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0.46
- gnomAD missense Z
- 0.83
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- aortic valve morphogenesis
- axon guidance
- central nervous system neuron differentiation
- endocardial cushion to mesenchymal transition involved in heart valve formation
- ephrin receptor signaling pathway
- mitral valve morphogenesis
- negative regulation of cell adhesion mediated by integrin
- negative regulation of dendritic spine morphogenesis
- negative regulation of epithelial to mesenchymal transition
- negative regulation of MAPK cascade
- negative regulation of proteolysis involved in protein catabolic process
- negative regulation of thymocyte apoptotic process
- negative regulation of transcription by RNA polymerase II
- notochord formation
- positive regulation of amyloid precursor protein catabolic process
- positive regulation of amyloid-beta formation
- positive regulation of intracellular signal transduction
- positive regulation of MAPK cascade
- protein stabilization
- regulation of angiogenesis
- regulation of axonogenesis
- regulation of blood vessel endothelial cell migration
- substrate adhesion-dependent cell spreading
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EFNA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EFNA1 as an antibody target. Whether an autoantibody or antibody against EFNA1 could matter depends on whether native EFNA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EFNA1 is annotated at the cell surface, where native EFNA1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EFNA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...